 "Chart Check: Reliance Industries, Arvind, Ajanta Pharma, Bank of India")
Here are a few trading ideas from Chandan Taparia of Anand Rathi for trade today:
BUY RELIANCE INDUSTRIES: The stock has given a consolidation breakout and surpassed its hurdle of Rs 1110 levels. It gave a price volume breakout on daily chart. It gave the highest daily close of last 28 months and according to its current price placement it is set for a strong upside move towards Rs 1070 and higher levels. Thus recommending buying the stock with the stop loss of Rs 1070 for the upside immediate target of Rs 1142 levels.
SELL AJANTA PHARMA: The stock is finding selling pressure at higher levels and is making lower highs lower lows from last two sessions. It fell below its previous support of Rs 1970 levels with fresh shorts being added in the counter with open interest addition of around 6.50% in previous session. One can sell the stock on a small bounce back move with strict stop loss of Rs 2040 for the downside target of Rs 1920 levels.
SELL BANK OF INDIA: The stock failed to cross the multiple hurdles of Rs 122-123 levels and formed a negative price structure. It has been witnessing built up of short position in the initial part of the series and shorts are indicating further downfall towards Rs 113 and lower levels. One can sell the stock with the stop loss of Rs 122 for the downside immediate target of Rs 113 levels.
Disclaimer: We are suggesting these stocks to our clients but not personal holdings.
Chandan Taparia is a Derivatives Analyst - Equity Research at Anand Rathi
BUY RELIANCE INDUSTRIES: The stock has given a consolidation breakout and surpassed its hurdle of Rs 1110 levels. It gave a price volume breakout on daily chart. It gave the highest daily close of last 28 months and according to its current price placement it is set for a strong upside move towards Rs 1070 and higher levels. Thus recommending buying the stock with the stop loss of Rs 1070 for the upside immediate target of Rs 1142 levels.
Also Read
BUY ARVIND: The stock headed towards its lifetime high levels even after sharp selling in the broader market. It gave the lifetime highest daily close and is continuously making higher top –higher bottom formation with support base shifting higher. The bulls are intact in the counter even at current price level thus supporting our positive view in the stock. So recommending buying the stock with the stop loss of Rs 344 for the upside immediate target of Rs 368 levels.
SELL AJANTA PHARMA: The stock is finding selling pressure at higher levels and is making lower highs lower lows from last two sessions. It fell below its previous support of Rs 1970 levels with fresh shorts being added in the counter with open interest addition of around 6.50% in previous session. One can sell the stock on a small bounce back move with strict stop loss of Rs 2040 for the downside target of Rs 1920 levels.
SELL BANK OF INDIA: The stock failed to cross the multiple hurdles of Rs 122-123 levels and formed a negative price structure. It has been witnessing built up of short position in the initial part of the series and shorts are indicating further downfall towards Rs 113 and lower levels. One can sell the stock with the stop loss of Rs 122 for the downside immediate target of Rs 113 levels.
Disclaimer: We are suggesting these stocks to our clients but not personal holdings.
Chandan Taparia is a Derivatives Analyst - Equity Research at Anand Rathi
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%